Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

Psoriatic Arthritis News

News
Dactylitis, Severe PsA More Likely with Early-Onset PsO
09/07/2022
Patients with psoriatic arthritis who develop psoriasis before age 40 are more likely to have severe disease and dactylitis, research shows.
Patients with psoriatic arthritis who develop psoriasis before age 40 are more likely to have severe disease and dactylitis, research shows.
Patients with psoriatic...
09/07/2022
Rheumatology & Arthritis

Advertisement

News
Are Psoriasis, Psoriatic Arthritis and Endometriosis Associated?
08/24/2022
Women diagnosed with psoriasis and psoriatic arthritis may be at a higher risk of developing endometriosis.
Women diagnosed with psoriasis and psoriatic arthritis may be at a higher risk of developing endometriosis.
Women diagnosed with psoriasis...
08/24/2022
Rheumatology & Arthritis
News
Early Identification of axPsA
08/22/2022
New research indicates that dermatologists can play a key role in screening patients with psoriasis to identify early signs of axial psoriatic arthritis.
New research indicates that dermatologists can play a key role in screening patients with psoriasis to identify early signs of axial psoriatic arthritis.
New research indicates that...
08/22/2022
Rheumatology & Arthritis
News
Weight-Loss Treatment Effective for Patients With PsA
08/11/2022
A recent study found that a structured weight-loss treatment for patients with psoriatic arthritis was successful in improving body weight and total body fat without compromising muscle strength.
A recent study found that a structured weight-loss treatment for patients with psoriatic arthritis was successful in improving body weight and total body fat without compromising muscle strength.
A recent study found that a...
08/11/2022
Rheumatology & Arthritis

Advertisement

News
Interleukin Inhibitors Effective Among TNFi-Exposed Patients With PsA
05/16/2022
Investigators set out to determine if interleukin-17 and -12/23 inhibitors were effective among patients with psoriatic disease who responded inadequately to tumor necrosis factor inhibitors.
Investigators set out to determine if interleukin-17 and -12/23 inhibitors were effective among patients with psoriatic disease who responded inadequately to tumor necrosis factor inhibitors.
Investigators set out to...
05/16/2022
Rheumatology & Arthritis
News
C-Reactive Protein Testing is More Widely Used in Europe than the US in the Diagnosis and Monitoring of Psoriatic Arthritis
01/31/2022
In a study published in Rheumatology Therapy, researchers investigated how CRP testing is implemented in real-world clinical practice for disease management of PsA.
In a study published in Rheumatology Therapy, researchers investigated how CRP testing is implemented in real-world clinical practice for disease management of PsA.
In a study published in...
01/31/2022
The Dermatologist
News
PROMIS On Par With HAQ Disability Index
01/25/2022
For determining minimal disease activity among patients with psoriatic arthritis, researchers found that the Patient-Reported Outcomes Measurement Information System can be a reliable alternative to the Health Assessment Questionnaire...
For determining minimal disease activity among patients with psoriatic arthritis, researchers found that the Patient-Reported Outcomes Measurement Information System can be a reliable alternative to the Health Assessment Questionnaire...
For determining minimal disease...
01/25/2022
Rheumatology & Arthritis

Advertisement

FDA Alerts
FDA Approves Risankizumab-rzaa for Adult Patients With Active Psoriatic Arthritis
01/24/2022
Jessica Garlewicz, Associate Digital Editor
The IL-23 inhibitor has already been approved for the treatment of plaque psoriasis.
The IL-23 inhibitor has already been approved for the treatment of plaque psoriasis.
The IL-23 inhibitor has already...
01/24/2022
The Dermatologist
News
Parallel Studies Identify, Compare Risk Factors for Inflammatory Conditions
01/12/2022
Researchers found some identical and some differing risk factors for developing psoriatic arthritis, psoriasis, rheumatoid arthritis, and ankylosing spondylitis.
Researchers found some identical and some differing risk factors for developing psoriatic arthritis, psoriasis, rheumatoid arthritis, and ankylosing spondylitis.
Researchers found some identical...
01/12/2022
Rheumatology & Arthritis
News
Dactylitis Useful in Risk Stratification for PsA
01/05/2022
Researchers found that patients with early psoriatic arthritis who were naïve to disease-modifying antirheumatic drugs and present with dactylitis could have more severe disease.
Researchers found that patients with early psoriatic arthritis who were naïve to disease-modifying antirheumatic drugs and present with dactylitis could have more severe disease.
Researchers found that patients...
01/05/2022
Rheumatology & Arthritis

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Popular Articles

News
Screening Process for axSpA Speeds Diagnosis
08/13/2021
Research shows high level of accuracy of a stratified process for evaluating patients with possible axial spondyloarthritis.
Research shows high level of accuracy of a stratified process for evaluating patients with possible axial spondyloarthritis.
Research shows high level of...
08/13/2021
Autoimmune
Mohamad Bittar, MD
Podcast
Nonrad AxSpA and the Disease Burden on the Patient
10/05/2023

Featuring Dr Mohamad Bittar

Featuring Dr Mohamad Bittar
Dr Bittar educates the listeners on the core differences and similarities between ankylosing spondylitis and axial spondyloarthritis; and provides guidance on diagnosing and monitoring/ treating patients with various forms of axial diseases.
Dr Bittar educates the listeners on the core differences and similarities between ankylosing spondylitis and axial spondyloarthritis; and provides guidance on diagnosing and monitoring/ treating patients with various forms of axial diseases.
Dr Bittar educates the listeners...
10/05/2023
Autoimmune
News
Expert Recommendations for Managing Autoimmune Bullous Diseases in COVID-19 Era
05/18/2020
Experts from the United States, France, and Germany published guidance on managing patients with autoimmune bullous diseases during the COVID-19 pandemic.
Experts from the United States, France, and Germany published guidance on managing patients with autoimmune bullous diseases during the COVID-19 pandemic.
Experts from the United States,...
05/18/2020
Autoimmune
News
Telemedicine Preferred Among Patients With Autoimmune Rheumatic Disease
01/27/2022
A recent study found that patients with autoimmune rheumatic disease were satisfied with video visits and even preferred telemedicine for certain visit reasons.
A recent study found that patients with autoimmune rheumatic disease were satisfied with video visits and even preferred telemedicine for certain visit reasons.
A recent study found that...
01/27/2022
Autoimmune
News
Mortality Among Patients With AS and nr-axSpA
10/03/2023

Jolynn Tumolo

Jolynn Tumolo
Researchers found differences in life expectancy among patients with ankylosing spondylitis and nonradiographic axial spondyloarthritis.
Researchers found differences in life expectancy among patients with ankylosing spondylitis and nonradiographic axial spondyloarthritis.
Researchers found differences in...
10/03/2023
Rheumatology & Arthritis

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Stay In the Know

Autoimmune Newsletter

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Privacy Policy Terms of Use